The multiple mechanisms of MCL1 in the regulation of cell fate H Widden, WJ Placzek Communications Biology 4 (1), 1029, 2021 | 70 | 2021 |
MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73 H Widden, A Kaczmarczyk, A Subedi, RH Whitaker, WJ Placzek Cell Death & Disease 11 (11), 946, 2020 | 15 | 2020 |
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma NJ Eustace, JC Anderson, JM Warram, HN Widden, RT Pedersen, ... Oncogene 39 (46), 6961-6974, 2020 | 14 | 2020 |
MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73 H Widden, A Kaczmarczyk, RH Whitaker, WJ Placzek Cancer Research 79 (13_Supplement), 2498-2498, 2019 | 1 | 2019 |
L-2-hydroxyglutarate remodeling of the epigenome and epitranscriptome creates a metabolic vulnerability in kidney cancer models A Kundu, GJ Brinkley, H Nam, S Karki, R Kirkman, M Pandit, EH Shim, ... The Journal of Clinical Investigation, 2024 | | 2024 |
L-2HG, oncometabolite-driven epigenetic and epitranscriptomic reprogramming creates metabolic vulnerability in renal cancer A Kundu, GJ Brinkley, H Nam, S Karki, R Kirkman, H Widden, M Johnson, ... Cancer Research 83 (7_Supplement), 3705-3705, 2023 | | 2023 |
PD17-08 EPIGENETIC AND EPITRANSCRIPTOMIC REPROGRAMMING IN RENAL CANCER BY ONCOMETABOLITE L-2HG CREATES METABOLIC VULNERABILITY G Brinkley, A Kundu, H Nam, S Karki, R Kirkman, H Widden, M Johnson, ... The Journal of Urology 209 (Supplement 4), e498, 2023 | | 2023 |
Inhibition of the SET/MLL Histone Methyltransferase Complex as a Novel Epigenetic Targeted Therapy in Mixed Lineage Leukemia H Widden, O Moukha‐Chafiq, R Whitaker, A Vadukoot, ... The FASEB Journal 35, 2021 | | 2021 |
The multiple mechanisms of MCL1 in the regulation of cell fate W Hayley, WJ Placzek Communications Biology 4 (1), 2021 | | 2021 |
Beyond Apoptosis: Insight into the Complex Intracellular Networks that Govern Cell Fate HN Widden The University of Alabama at Birmingham, 2021 | | 2021 |
Transcriptional Activation of Tumor Suppressor p73 is Modulated by MCL1 Through a Novel Protein Interaction H Widden, A Kacmarczyk, RH Whitaker, WJ Placzek The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
EXTH-52. USE OF A PHOSPHOLIPID BINDING MARCKS MIMETIC FOR TARGETED KILLING OF GLIOBLASTOMA CELLS N Eustace, J Warram, H Widden, J Anderson, P Hicks, R Troelsgaard, ... Neuro-Oncology 20 (suppl_6), vi96-vi96, 2018 | | 2018 |